Morphologically-Directed Raman Spectroscopy: Uncovering the Good, the Bad, and the Ugly in Drug Formulations.

MDRS differentiates the API from the product matrix and enables measurement of particle size and shape.

Detalles Bibliográficos
Publicado en:Pharmaceutical Technology Vol. 41; no. 4; pp. 60 - 63
Autor principal: Langley, Cathryn
Formato: Journal Article
Publicado: MJH Life Sciences Apr2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=122469013&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 122469013
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15432521
        4FK
      jtl: Pharmaceutical Technology
      issn: 15432521
      maglogo: N
    pubinfo:
      dt: Apr2017
      vid: 41
      iid: 4
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        122469013
        122469013
      ppf: 60
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Morphologically-Directed Raman Spectroscopy: Uncovering the Good, the Bad, and the Ugly in Drug Formulations.
      aug:
        au: Langley, Cathryn
        affil: Associate product manager, analytical imaging, Malvern Instruments Ltd, Enigma Business Park, Grovewood Road, Malvern, Worcestershire, WR14 1XZ, UK
      sug:
      ab: MDRS differentiates the API from the product matrix and enables measurement of particle size and shape.
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N